| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江苏爱朋医疗科技股份有限公司自2001年成立以来，积极投身于中国舒适化医疗健康事业，始终以临床需求为出发点，以循证医学为研发依据，以匠心品质为经营理念，在疼痛管理和鼻腔护理两个细分领域持续深耕多年，立志成为医疗细分行业内“舒适化医疗智能设备领先者”。目前旗下拥有爱普科学仪器（江苏）有限公司、上海诺斯清生物科技有限公司、江苏爱众医蕙医疗科技有限公司、江苏朋众医蕙医疗科技有限公司、江苏爱朋医疗科技发展有限公司、四川金佳钲医疗器械有限公司、上海小芃科技有限公司、深圳市百士康医疗设备有限公司、爱朋医疗科技（湖南）有限公司。 公司是专业从事疼痛管理及鼻腔护理领域用医疗器械产品研发、生产及销售的高新技术企业，主要产品包括微电脑注药泵、一次性注药泵、无线镇痛管理系统、脉搏血氧仪及传感器等疼痛管理领域用医疗器械和鼻腔护理喷雾器等鼻腔护理领域用医疗器械。其中，疼痛管理领域用医疗器械主要用于术后、分娩、癌症等临床治疗中药液的输注和监测，缓解患者疼痛；鼻腔护理领域用医疗器械主要用于缓解患者鼻腔干燥、鼻塞、鼻出血等不适症状。 | ||||||||||||||||||||||||
| Main Business | 从事疼痛管理及鼻腔护理领域用医疗器械产品研发、生产及销售。 | ||||||||||||||||||||||||
| Legal Representative | 王凝宇 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 缪飞 | ||||||||||||||||||||||||
| Solicitors | 北京德恒律师事务所 | ||||||||||||||||||||||||
| Auditors | 天健会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0513-80158003 | ||||||||||||||||||||||||
| Fax No | 0513-80158003 | ||||||||||||||||||||||||
| Website | www.apon.com.cn | ||||||||||||||||||||||||
| apon@apon.com.cn | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 13/12/2018 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ 0.066 | ||||||||||||||||||||||||
| DPS(RMB)* | ¥ 0.065 | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 5.523 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 1.002B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |